GO
Loading...

Marijuana meets biotech

Friday, 20 Jun 2014 | 5:15 PM ET

Justin Gover, GW Pharmaceuticals CEO, discusses pivotal trials with its epilepsy drug and weighs in on Sativex, a cannabinoid medicine to treat cancer pain.